Urinary tract infections in women

Medical Clinics of North America

Volumn 95, Issue 1, 2011, Pages 27-41

  Dielubanza, Elodi J ^a   Schaeffer, Anthony J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cystitis; Recurrent; Urinary tract infection; Women

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ESTRIOL; ESTROGEN; FOSFOMYCIN TROMETAMOL; FURODANTIN; LEVOFLOXACIN; NITROFURANTOIN; NONOXINOL 9; PROGESTERONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPERMICIDAL AGENT; TRIMETHOPRIM; UNCLASSIFIED DRUG;

AGING; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIURIA; BEHAVIOR MODIFICATION; CANDIDA ALBICANS; CHLAMYDIA TRACHOMATIS; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRACEPTION; CYSTITIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DRUG MONITORING; ENTEROBACTERIACEAE; ERADICATION THERAPY; ESCHERICHIA COLI; ESTROGEN THERAPY; FEMALE; FLUID INTAKE; FOLLOW UP; GENETIC PREDISPOSITION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATURIA; HERPES SIMPLEX; HUMAN; INDWELLING CATHETER; INFECTION RISK; INTERMITTENT CATHETERIZATION; INTERSTITIAL CYSTITIS; LACTOBACILLUS; MENOPAUSE; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT CARE; PATIENT MONITORING; PERSONAL HYGIENE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PYELONEPHRITIS; RECURRENT INFECTION; REVIEW; RISK REDUCTION; SANITARY PAD; SELF MEDICATION; SEX DIFFERENCE; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; TAMPON; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; URETHRITIS; URINALYSIS; URINARY CATHETER; URINARY TRACT DISEASE; URINARY TRACT INFECTION; URINE CULTURE; URINE INCONTINENCE; VAGINA FLORA; VAGINITIS; WOMEN'S HEALTH;

AGE FACTORS; ANTI-BACTERIAL AGENTS; CLINICAL PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; PRIMARY HEALTH CARE; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 78649385067     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.08.023     Document Type: Review

References (57)

1. Foxman B. Epidemiology of urinary tract infection infections: incidence, morbidity, and economic cost. Am J Med 2002, 113(Suppl 1A):5S-13S.
2. Kunin C.M., Zacha E., Paquin A.J. Urinary tract infections in schoolchildren: I. Prevalence of bacteriuria and associated urologic findings. N Engl J Med 1962, 266:1287-1296.
3. Raz R. Asymptomatic bacteriuria: clinical significance and management. Int J Antimicrob Agents 2003, 22(2):45-47.
4. Schaeffer A.J., Schaeffer E.M. Infections of the urinary tract. Campbell-Walsh urology 2007, 223-302. Saunders Elsevier, Philadelphia. 9th edition. A.J. Wein, L.R. Kavoussi (Eds.).
5. Nicolle L.E., Ronald A.R. Recurrent urinary tract infection in women: diagnosis and treatment. Infect Dis Clin North Am 1987, 1(4):793-806.
6. Harrison W.O., Holmes K.K., Belding M.E., et al. A prospective evaluation of recurrent urinary tract infection in women. Clin Res 1974, 125A.
7. Czaja C.S., Stamm W.E. Hooton TM. Prospective cohort study of microbial and inflammatory events immediately precede Escherichia coli recurrent urinary tract infection. J Infect Dis 2009, 200:528-536.
8. Stamey T.A., Timothy M.M. Studies of introital colonization in women with recurrent urinary infections: I. The role of vaginal pH. J Urol 1975, 114:261-263.
9. Hooton T.M., Stapleton A.E., Stamm W.E. Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis 1999, 29:1600-1601.
10. Foxman B., Geiger A.M., Palin K., et al. First-time urinary tract infection and sexual behavior. Epidemiology 1995, 6:162-168.
11. Hooton T.M., Scholes D., Stamm W.E. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996, 335:468-474.
12. Handley M.A., Reingold A.L., Shiboski S., et al. Incidence of acute urinary tract infection in young women and use of male condoms with and without Nonoxynol-9 spermicides. Epidemiology 2002, 13:431-436.
13. Smith H.S., Hughes J.P., Hooton T.M., et al. Antecedent antimicrobial use increases the risk of uncomplicated UTI in young women. Clin Infect Dis 1997, 25:63-68.
14. Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J Urol 2002, 168:1720-1722.
15. Hillier S., Roberts Z., Dunstan F., et al. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother 2007, 60:92-99.
16. Colodner R., Kometiani, Chazan B., et al. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E coli. Infection 2008, 36:41.
17. Scholes D., Hooton T.M., Roberts P.L., et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000, 182:1777.
18. Beisel B., Hale W., Graves R.S., et al. Clinical inquiries: does postcoital voiding prevent urinary tract infections in young women. J Fam Pract 2002, 51(11):977.
19. Schaeffer A.J., Jones J.M., Falkowski W.S., et al. Adhesion of uropathogenic E coli to epithelial cells from women with recurrent urinary tract infection. Infection 1982, 10(3):186-191.
20. Shenfield J., Schaeffer A.J., Cordon-Cardo C., et al. Association of Lewis blood group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989, 320:773-777.
21. Schaeffer A.J., Radway R.M., Chmiel J.D. Human leukocyte antigens in women with recurrent urinary tract infections. J Infect Dis 1982, 148(3):604.
22. Stamm W.E., Raz R. Factors contributing to susceptibility of post-menopausal women to recurrent urinary tract infections. Clin Infect Dis 1999, 28:723-725.
23. Raz R., Stamm W.E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993, 329:753-756.
24. Orlander J.D., Jick S.S., Dean A.D., et al. Urinary tract infections and estrogen use in older women. J Am Geriatr Soc 1992, 40:817-820.
25. Anger J.T., Litwin M.S., Wang Q., et al. Complications of sling surgery among female medicare beneficiaries. Obstet Gynecol 2007, 109:707-714.
26. Wullt B., Connell H., Rollano P., et al. Urodynamic factors influence the duration of Eschericia coli bacteria in deliberately colonized cases. J Urol 1998, 159:2057-2062.
27. Nicole L.E., Bradley S., Colgan R., et al. Infectious disease society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin infect Dis 2005, 40:643-654.
28. Nicolle L.E., Bentley D., Garibaldi R., et al. Antimicrobial use in long-term care facilities. Infect Control Hosp Epidemiol 1996, 17(2):119-128.
29. Nicolle L.E. Urinary tract infections in long-term care facilities. Infect Control Hosp Epidemiol 2001, 22:167-175.
30. King R.B., Carlson C.E., Mervine J., et al. Clean and sterile intermittent catheterization methods in hospitalized patients with spinal cord injury. Arch Phys Med Rehabil 1992, 3(9):798-802.
31. Stamm W.E. Urinary tract infections. Hospital infections 1998, Lippincott-Raven, Philadelphia, p.477-85. 4th edition.
32. Tambyah P.A., Maki D.G. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1497 catheterized patients. Arch Intern Med 2000, 160:678-682.
33. Warren J.W., Damron D., Tenney J.H., et al. Fever, bacteremia, and death as complications of bacteriuria in women with long-term indwelling urethral catheters. J Infect Dis 1987, 155:1151-1158.
34. Stamey T.A. Pathogenesis and treatment of urinary tract infections 1980, Williams & Wilkins, Baltimore (MD).
35. Mazor-Dray E., Levy A., Schlaeffer F., et al. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome. J Matern Fetal Neonatal Med 2009, 22(2):124.
36. Aronson M., Medalia O., Schori L., et al. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. J Infect Dis 1979, 139(3):329-332.
37. Hultgren S.J., Porter T.N., Schaeffer A.J., et al. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun 1985, 50(2):370-377.
38. Anderson G.G., Martin S.M., Hultgren S.J. Host subversion by formation of intracelluar bacterial communities in the urinary tract. Microbes Infect 2004, 6:1094-1101.
39. Vaisanen V., Elo J., Tallgren L.G., et al. Mannose-resistant haemagglutination and p antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet 1981, 2:1366-1369.
40. Silverblatt F.J., Dryer J.S., Schauer S. Effect of pili on susceptibility to phagocytosis. Infect Immun 1979, 24(1):218-223.
41. Ovalle A., Levancini A. Urinary tract infections in pregnancy. Curr Opin Urol 2001, 11(1):55-59.
42. Pfaller M., Rigenberg B., Rames L., et al. The usefulness of screening tests for pyuria in combination with urine culture in the diagnosis of urinary tract infection. Diagn Microbiol Infect Dis 1987, 6(3):207-215.
43. Bent S., Saint S. Optimal use of diagnostic testing in women with acute uncomplicated cystitis. Am J Med 2002, 113:21-28.
44. Kraft J.K., Stamey T.A. The natural history of symptomatic recurrent bacteriuria in women. Medicine (Baltimore) 1977, 56:55-60.
45. Mabeck C.E. Studies in urinary tract infections: I. The diagnosis of bacteriuria in women. Acta Med Scand 1969, 186:35-38.
46. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. N Engl J Med 1993, 329:1328-1334.
47. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990, 80:331-333.
48. Warren J.W., Abrutyn E., Hebel J.R., et al. Infectious diseases society for the antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999, 29:745-758.
49. Milo G., Katchman E., Paul M., et al. Duration of antibacterial treatment for uncomplicated urinary tract infections in women. Cochrane Database Syst Rev 2005, 2. CD004682.
50. Zhanel G.G., Hisanaga T.L., Laing N.M., et al. Antibiotic resistance in outpatient urinary isolates: final results from the North American urinary tract infection collaborative alliance (NAUTICA). Int J Antimicrob Agents 2006, 27(6):468-475.
51. Kashanian J., Hakimian P., Shabsigh R. Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int 2008, 102:1634-1637.
52. Wagenlehner F.M., Weidner W., Naber K.G. An update on uncomplicated urinary tract infections in women. Curr Opin Urol 2009, 19:268-274.
53. Schito G.C., Naber K.G., Botto H. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009, 34:407-413.
54. Stein G.E. Comparison of single dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther 1999, 2(11):1864-1872.
55. Minassian M.A., Lewis D.A., Chattopadhyay D., et al. A comparison between single-dose fosfomycin trometamol (monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents 1998, 10(1):39-47.
56. Kalowsky J.A., Hoban D.J., DeColby M.R., et al. Fluroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American urinary tract infection collaborative alliance- quinolone resistance study. Antimicrob Agents Chemother 2006, 50(6):2251-2254.
57. Schaeffer A.J., Stuppy B.A. Efficacy and safety of self-start therapy in women with recurrent urinary tract infection. J Urol 1999, 161:207-211.